
Rekvina Labs Ltd Hits New 52-Week High at Rs.27.68
2026-03-02 13:41:00Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.27.68, marking a significant milestone in its stock performance. This new peak reflects sustained momentum, with the stock demonstrating robust gains over the past three weeks and outperforming its sector peers.
Read full news article
Rekvina Labs Ltd Hits New 52-Week High of Rs.27.14 on 27 Feb 2026
2026-02-27 11:19:08Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.27.14 today, reflecting a remarkable rally that has seen the stock more than double over the past three weeks. This milestone underscores the stock’s robust momentum amid a broader market environment where the Sensex has experienced a modest decline.
Read full news article
Rekvina Labs Ltd Hits New 52-Week High of Rs.26.61 on 26 Feb 2026
2026-02-26 10:54:41Rekvina Labs Ltd achieved a significant milestone on 26 Feb 2026, reaching a new 52-week high of Rs.26.61. This marks a remarkable rally for the stock, which has demonstrated strong momentum over the past three weeks, outperforming its sector and trading well above key moving averages.
Read full news article
Rekvina Labs Ltd Hits New 52-Week High of Rs.26.09 on 25 Feb 2026
2026-02-25 10:54:41Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.26.09 today, reflecting a remarkable rally that has seen the stock gain 138.48% over the past 21 trading sessions. This milestone underscores the stock’s strong momentum and sustained upward trajectory in recent weeks.
Read full news article
Rekvina Labs Ltd Hits New 52-Week High of Rs.25.58 on 24 Feb 2026
2026-02-24 11:19:41Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.25.58 today, reflecting a remarkable rally that has seen the stock gain over 145% in the past 21 trading sessions. This milestone underscores the stock’s robust upward momentum, significantly outperforming its sector and broader market indices despite a subdued Sensex environment.
Read full news article
Rekvina Labs Ltd Hits New 52-Week High at Rs.25.08
2026-02-23 10:38:23Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.25.08 today, reflecting a remarkable rally that has seen the stock gain over 150% in the past 21 trading sessions. This milestone underscores the stock’s robust momentum and sustained upward trajectory across multiple moving averages.
Read full news article
Rekvina Labs Ltd Hits New 52-Week High at Rs.24.59
2026-02-20 14:40:40Rekvina Labs Ltd achieved a significant milestone on 20 Feb 2026, reaching a new 52-week high of Rs.24.59. This marks a continuation of a strong upward momentum, with the stock registering gains for 21 consecutive trading sessions and delivering a remarkable 159.94% return over this period.
Read full news article
Rekvina Labs Ltd Hits New 52-Week High of Rs.24.11 on 19 Feb 2026
2026-02-19 10:48:20Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.24.11 today, reflecting a remarkable rally that has seen the stock gain 167.59% over the past 21 trading sessions. This milestone underscores the strong momentum the stock has built, trading well above all key moving averages and outperforming its sector in recent sessions.
Read full news article
Rekvina Labs Ltd Hits New 52-Week High of Rs.23.64 on 18 Feb 2026
2026-02-18 11:11:44Rekvina Labs Ltd reached a fresh 52-week high of Rs.23.64 today, underscoring a remarkable rally that has seen the stock surge by 175.2% over the past 21 trading sessions. This milestone highlights the stock’s strong momentum amid a mixed market backdrop.
Read full news articleFinancial Results For The Quarter And Nine Months Ended On 31St December 2025.
09-Feb-2026 | Source : BSERegulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 06th February 2026 has inter-alia adopted and approved. 1. Financial Results for the Quarter and Nine Month ended on 31st December 2025. 2. Limited Review Report by Statutory Auditor of the Company on Standalone in-audited Financial Results for the Nine Month & Quarter ended on 31st December 2025.
Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February 2026
06-Feb-2026 | Source : BSEDear Sir/Madam Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 6th February 2026 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:32 P.M. This is for your information and record Thanking you For Rekvina Laboratories Limited
Announcement under Regulation 30 (LODR)-Change in Directorate
29-Jan-2026 | Source : BSEPursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 29th January 2026 have considered and approve appointment of Mr. Jay Chintan Patel as an Additional Non-Executive Independent Director.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Rekvina Labs Ltd has announced 5:10 stock split, ex-date: 30 Apr 14
No Bonus history available
No Rights history available






